共 20 条
[6]
Carriage of Cytochrome 2C19 Polymorphism Is Associated With Risk of High Post-Treatment Platelet Reactivity on High Maintenance-Dose Clopidogrel of 150 mg/day Results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) Study
[J].
JACC-CARDIOVASCULAR INTERVENTIONS,
2010, 3 (07)
:731-741
[7]
Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction Results of the Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With AMI (ACCEL-AMI) Study
[J].
CIRCULATION-CARDIOVASCULAR INTERVENTIONS,
2010, 3 (01)
:17-U36
[10]
Drug-eluting stenting followed by cilostazol treatment reduces late Restenosis in patients with diabetes mellitus - The DECLARE-DIABETES trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients)
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2008, 51 (12)
:1181-1187